Report copyright - Phase I study safety and tolerability of Varlitinib (VAR ...aslanpharma.com/app/uploads/2018/10/ESMO-2018-poster-ASLAN001.pdf · 3+3 dose escalation except FOL + VAR 300mg/BID with
Please pass captcha verification before submit form